Providing market intelligence for more than 35 years

In The News

Apple TV+ serves MLS Sunday matches, expands Season Pass distribution partnerships

Bringing another marquee sports night could be good for Apple TV+, which by some estimates lags well behind other major SVODs in terms of U.S. uptake.

And in a recent column on StreamTV Insider, Parks Associates’ Jennifer Kent pegged sports as a key differentiator to watch for in 2025, as platforms evolve the viewing experience and offer more interactive capabilities.

“Platforms will continue to battle it out over sports rights as well as other sports-centric exclusive and shoulder content with the goal of ultimately attracting and retaining these highly desirable viewers,” wrote Kent. “Ultimately, sports fans will be better served with a more organized and immersive fan-centric experience.”

From the article, "Apple TV+ serves MLS Sunday matches, expands Season Pass distribution partnerships" by Bevin Fletcher

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...